Immune Response licenses Hybridon's AMPLIVAX vaccine adjuvant.

BIOTECH Patent News | October 1, 2003 | Copyright

The Immune Response Corporation (Carlsbad, CA) and Hybridon, Inc. (Cambridge, MA) have entered into a license agreement for the use of AMPLIVAX as an adjuvant in the development of a novel vaccine candidate for the prevention and treatment of HIV, the virus that causes AIDS. The new vaccine candidate, which has already demonstrated activity in laboratory experiments, combines the whole-killed vaccine technology employed in REMUNE, an immune-based HIV therapeutic vaccine being evaluated in Phase II clinical trials by The Immune Response Corporation, plus AMPLIVAX, Hybridon's 2nd ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Biotech faces cash shortage, explores funding options: Immune's CFO resigns, research revenue down. (Tech Talk).
Magazine article from: San Diego Business Journal ; Immune Response Corp. said its auditors have questioned...equivalents and short-term investments. Immune Response said the cash will fund operations...said Kathy Lane, a spokeswoman for Immune Response. Immune Response said it raised...
Investors Like Reports on Immune Response.(Brief Article)(Statistical Data Included)
Magazine article from: San Diego Business Journal ; It was as if Immune Response Corp. awakened from the dead...a stock resurgence. Shares of Immune Response climbed as much as 115 percent...excitement, however, was short-lived. Immune Response shares dropped to $2.18 on April...
Immune Response Stock Dips After Study.(securities information)(Brief Article)(Statistical Data Included)
Magazine article from: San Diego Business Journal ; Shares of Immune Response Corp. continued to hover in the...expectations. The issue is, (Immune Response) had a high-risk drug and did...Remune. McCamant, however, said Immune Response has made a mistake by alienating...
Immune Response Pins Hopes on Study Results.(Brief Article)
Magazine article from: San Diego Business Journal ; Officials at Immune Response Corp. said they will rely primarily...however, raised concerns whether Immune Response will be able to convince regulators...other data (to get approved). Immune Response said Aug. 30 it will not pursue...
Immune Response Corp. warns of bankruptcy filing. (Biotech).(Brief Article)
Magazine article from: San Diego Business Journal ; Carlsbad-based Immune Response Corp. warned in a regulatory...unable to raise additional funds. Immune Response said Nov. 20 it wants to raise...said the funding depends on Immune Response's ability to cut costs. The...
Immune response cuts staff; looks for new CEO: Dennis Carlo resigns as chief exec of troubled AIDS firm. (Biotech).(Brief Article)(Statistical Data Included)
Magazine article from: San Diego Business Journal ; Immune Response Corp., a Carlsbad-based biotech...more than half of its workforce. Immune Response named Dr. Ronald Moss, formerly...fund-raising effort, said Michael Jeub, Immune Response's CFO. As of Sept. 12, the company...
Immune Response Bears Brunt of Partner's Pullout.(Agouron Pharmaceuticals will no longer fund development of its experimental HIV vaccine, Remune)(Brief Article)
Magazine article from: San Diego Business Journal ; ...HIV Vaccine Development CARLSBAD -- Immune Response Corp. barely announced the withdrawal...on behalf of shareholders against Immune Response. Laura Hansen, a company spokeswoman...withdrawal as disappointing, but said Immune Response plans to develop Remune on its own...
Bitter Publication Dispute on Remune Study: More Than Meets the Eye?
Newspaper article from: AIDS Treatment News ; ...Times reported that the Immune Response Corporation tried to block the publication...from the fact that today immune-based therapy is an enormously...FDA Meeting on Approving Immune Therapies: Background and...353, October 20, 2000). Immune Response Corporation did what ...
Immune Response Stock Drops After Test Results.(disappointing results for Remune, AIDS drug)(Brief Article)(Statistical Data Included)
Magazine article from: San Diego Business Journal ; ...Called Unimportant CARLSBAD -- Stock in Immune Response Corp. lost more than half its value...Berkeley-based Medical Technology Stock Letter. Immune Response reported June 1 that HIV-positive...said Laura Hansen, a spokeswoman for Immune Response. Immune Response's ...
Immune Response searches for white knight. (High-Tech).(Brief Article)(Statistical Data Included)
Magazine article from: San Diego Business Journal ; The clock is ticking for Immune Response Corp. A company official said...the end of this month when Immune Response is expected to run out of...head of investor relations at Immune Response. Lawhead said Immune Response...

Find more facts and information related to the article "Immune Response licenses Hybridon's AMPLIVAX ..."